Beyond organ preservation: Response patterns and salvage outcomes in anal canal squamous cell carcinoma

Anal canal squamous cell carcinoma (SCC) is an uncommon malignancy treated primarily with definitive chemoradiotherapy (CCRT). However, treatment responses and long-term outcomes remain heterogeneous. We retrospectively analysed six patients with non-metastatic anal canal SCC treated with definitive CCRT between 2019 and 2024 at a tertiary oncology centre. Clinical presentation, treatment techniques, toxicities, response patterns, salvage interventions, and survival outcomes were evaluated. Stages ranged from IIA to IIIC. Radiotherapy techniques included 3DCRT, IMRT, and VMAT with concurrent mitomycin-based chemotherapy. Four patients achieved durable disease control, including one after salvage pelvic exenteration. Two patients developed persistent or recurrent disease and subsequently died. Acute toxicities were manageable, with only one Grade 3 dermatitis event . Anal canal SCC demonstrates variable clinical behaviour despite standardized CCRT. Careful response assessment, individualized surveillance, and timely salvage treatment remain crucial for optimizing outcomes .

Authors

Institutions

Publication Details

Journal
Indian Journal of Pathology and Oncology
Published
2026-11-16
DOI
https://doi.org/10.18231/j.ijpo.17722.1793254680
Primary Topic
Colorectal and Anal Carcinomas
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond organ preservation: Response patterns and salvage outcomes in anal canal squamous cell carcinoma

Papuji Meher, Amit Kumar Chowhan, Siddhartha Nanda, Mukesh Kumar et al.
Indian Journal of Pathology and Oncology
Colorectal and Anal Carcinomas
article

Beyond organ preservation: Response patterns and salvage outcomes in anal canal squamous cell carcinoma

Papuji Meher, Amit Kumar Chowhan, Siddhartha Nanda, Mukesh Kumar, Amitima Mehta
article en

Abstract

Anal canal squamous cell carcinoma (SCC) is an uncommon malignancy treated primarily with definitive chemoradiotherapy (CCRT). However, treatment responses and long-term outcomes remain heterogeneous. We retrospectively analysed six patients with non-metastatic anal canal SCC treated with definitive CCRT between 2019 and 2024 at a tertiary oncology centre. Clinical presentation, treatment techniques, toxicities, response patterns, salvage interventions, and survival outcomes were evaluated. Stages ranged from IIA to IIIC. Radiotherapy techniques included 3DCRT, IMRT, and VMAT with concurrent mitomycin-based chemotherapy. Four patients achieved durable disease control, including one after salvage pelvic exenteration. Two patients developed persistent or recurrent disease and subsequently died. Acute toxicities were manageable, with only one Grade 3 dermatitis event . Anal canal SCC demonstrates variable clinical behaviour despite standardized CCRT. Careful response assessment, individualized surveillance, and timely salvage treatment remain crucial for optimizing outcomes .

Indian Journal of Pathology and OncologyVol. 13(4)
All India Institute of Medical Sciences Raipur (IN)
Good health and well-being
Colorectal and Anal Carcinomas
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon